- $778.49m
- $694.82m
- $279.06m
- 99
- 29
- 92
- 85
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 254 | 245 | 257 | 267 | 279 |
Cost of Revenue | |||||
Gross Profit | 150 | 155 | 166 | 176 | 184 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 239 | 229 | 249 | 254 | 263 |
Operating Profit | 14.7 | 15.8 | 8.05 | 12.4 | 16 |
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 17.9 | 17.8 | 7.77 | 15.6 | 18.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | 14.2 | 14.1 | 5.84 | 12.1 | 15.2 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 15.8 | 14.1 | 5.84 | 12.1 | 15.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 15.8 | 14.1 | 5.84 | 12.1 | 15.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.438 | 0.441 | 0.185 | 0.394 | 0.496 |
Dividends per Share |